Stock Ratings / Consumer Discretionary / PASW

TLF (43) BIRD (37) NCI (42) BRIA (56) ⌘ Pro Terminal →

Ping An Biomedical Co. Ltd. (Class A) (PASW) — RQD Stock Rating Cockpit

$5.00 -0.20% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Ping An Biomedical Co. Ltd. (Class A) (PASW) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $15.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PASW)Realized 20D OHLCV Swing Band: ±12.5%

RSI-14 MOMENTUMNEUTRAL RANGE

51.730 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

1 / 99-Pt Accounting

52-WEEK LASER RANGE7% OF RANGE

L: $3$5.00H: $29

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 10 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 14 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on PASW

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (50)

14.0% ROIC with 2.8% gross margin and -5.77% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (40)

Altman-Z 4.20 and Piotroski 1/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (27)

10/40 institutional & smart-money positioning score with 6/20 macro alignment.

Bull Case: Why Buyers Like PASW

✓Established market leader in Consumer Discretionary with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PASW)

✓Walkthrough of PASW's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PASW // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -20.38%📐 HORIZONTAL RANGE

2026-10-30O $5.33H $5.53L $4.30C $5.00VOL 62.3K

RES: $10.83SUP: $2.88SMA50: $5.15SMA200: $6.11

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PASW Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PASW Butterfly Map → + Track PASW →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PASW today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PASW. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PASW today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PASW)

Consumer Discretionary Rank #923 of 1011 ⚔️ TLF vs PASW Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (PASW vs. TLF, BIRD, NCI, BRIA)

Industry: Apparel (27 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Ping An Biomedical Co. Ltd. (Class A) (PASW) ranks #923 by composite RQD confidence (34/100, grade E) and #897 by equity capitalization ($15.6M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. BRIA currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with PASW at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PASW ACTIVE Ping An Biomedical Co. Ltd. (Class A)	E	34/100	—	2.8%	—	-0.20%	$15.6M	Benchmark Subject
TLF Tandy Leather Factory Inc.	D-	43/100	—	57.0%	-2.1%	+0.44%	$18.5M	/tlf-vs-pasw →
BIRD Smartbird Inc. (Class A)	D-	37/100	—	41.0%	-35.0%	-0.93%	$25.0M	/bird-vs-pasw →
NCI Neo-Concept International Group Holdings Limited (Class A)	D-	42/100	153.8x	36.9%	2.6%	-1.68%	$6.6M	/nci-vs-pasw →
BRIA BrilliA Inc (Class A)	D+	56/100	—	—	—	-4.11%	$42.9M	/bria-vs-pasw →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0001897532

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Ping An Biomedical Co. Ltd. (Class A) (PASW) reported GAAP revenue of $4.8M , GAAP net income of -$1.8M, operating cash flow of -$902.9K, and free cash flow of -$902.9K . On the balance sheet, PASW closed FY2025 with $9.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-09-30	$4.8M	-$1.8M	-$902.9K	-$902.9K	$9.6M	—

3. PASW Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PASW stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Ping An Biomedical Co. Ltd. (Class A) (NASDAQ: PASW) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $5.00 (-0.20% 1D, market cap $15.6M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, PASW ranks #923 in composite RQD confidence.

How does PASW compare to TLF and BIRD in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), PASW carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 2.8%, and ROIC of —. By comparison, TLF (Tandy Leather Factory Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -2.1%, cap $18.5M) and BIRD (Smartbird Inc. (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $25.0M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PASW?

Per PASW's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001897532), Ping An Biomedical Co. Ltd. (Class A) generated $4.8M in revenue, -$1.8M in net income, and -$902.9K in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PASW trading relative to its 50-day, 200-day, and 52-week technical levels?

PASW last traded at $5.00 (-0.20% on volume of 64,106 shares), positioning the stock -2.91% below its 50-day simple moving average ($5.15) and -18.17% below its 200-day simple moving average ($6.11). Across its 52-week range of $3.07 to $29.28, PASW sits at the 7.4% percentile with a 14-day RSI of 51.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.37 to $5.63).

PASW Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell PASW stock right now?

Ping An Biomedical Co. Ltd. (Class A) (PASW) currently earns a Roarable Rating of E (Strong Sell — SELL) with 34/100 RQD Confidence. Stretched risk/reward at current multiples (3% profit margin) under elevated 10-year interest-rate pressure.

What is PASW's 12-month price target and RQD AI Jury consensus?

PASW's 12-month base price target is $4.46 (range $3.48 to $30.74), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: PASW RQD Cockpit PASW 12M Forecast PASW Earnings & Move PASW Dividends & DRIP PASW Insiders & 13F PASW Whale Options PASW Profit Sankey PASW News & Why